Immunovia Publishes Interim Report for January-March 2024 [Yahoo! Finance]
Onconetix, Inc. (ONCO)
Company Research
Source: Yahoo! Finance
Net earnings amounted to KSEK -2,946 (-51,658), where exchange rate effects of KSEK 21 358 (435) had a substantial impact. Earnings per share before and after dilution were SEK -0.07 Cash Flow from operating activities amount MSEK -24.4 (39.7). Cash and equivalents at the end of the period amounted to MSEK 51.2 (68.2). On January 31 , the Company announced that Norma Alonzo Palma had been appointed Vice President of Clinical and Medical Affairs Significant events after the period On April 9 , the Company announced that Immunovia had successfully developed accurate and precise assays to measure targeted proteins for its next-generation test. On April 22 , the Company announced positive results from the model-development study for its next-generation pancreatic cancer detection test. CEO's comments I am proud to report that we delivered on our promises in transforming Immunovia to a new and more agile company with a significantly lower cost base, faster pace, greater
Show less
Read more
Impact Snapshot
Event Time:
ONCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ONCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ONCO alerts
High impacting Onconetix, Inc. news events
Weekly update
A roundup of the hottest topics
ONCO
News
- UT Health San Antonio to lead $11 million, NIH-funded study of a first-ever oral chlamydia vaccine [Yahoo! Finance]Yahoo! Finance
- Immunovia appoints Dr. Lisa Ford as Clinical Laboratory Director [Yahoo! Finance]Yahoo! Finance
- Immunovia Publishes Interim Report for January-March 2024 [Yahoo! Finance]Yahoo! Finance
- Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study [Yahoo! Finance]Yahoo! Finance
- Immunovia Publishes Full Year Report for 2023 [Yahoo! Finance]Yahoo! Finance
ONCO
Sec Filings
- 5/15/24 - Form NT
- 5/13/24 - Form 8-K
- 4/26/24 - Form S-1/A
- ONCO's page on the SEC website